$926 Million is the total value of Rhenman & Partners Asset Management AB's 94 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 22.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HZNP | Sell | HORIZON THERAPEUTICS PUB LTD | $41,685,000 | +40.7% | 750,000 | -25.0% | 4.50% | +8.5% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $39,918,000 | +45.9% | 137,500 | +19.6% | 4.31% | +12.5% |
| UNH | Buy | UNITEDHEALTH GROUP INC | $30,970,000 | +55.2% | 105,000 | +31.2% | 3.35% | +19.7% |
| ABBV | Sell | ABBVIE INC | $29,454,000 | +17.1% | 300,000 | -9.1% | 3.18% | -9.7% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $23,435,000 | +50.0% | 190,000 | +2.8% | 2.53% | +15.7% |
| BMY | Buy | BRISTOL MYERS SQUIBB CO | $22,344,000 | +14.5% | 380,000 | +8.6% | 2.41% | -11.7% |
| NVCR | Buy | NOVOCURE LTD | $22,238,000 | -8.3% | 375,000 | +4.2% | 2.40% | -29.3% |
| ESPR | Sell | ESPERION THERAPEUTICS INC NE | $21,807,000 | +16.7% | 425,000 | -28.3% | 2.36% | -10.0% |
| HUM | Buy | HUMANA INC | $21,326,000 | +50.9% | 55,000 | +22.2% | 2.30% | +16.4% |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $21,326,000 | +48.4% | 190,000 | +18.8% | 2.30% | +14.5% |
| CI | Buy | CIGNA CORP NEW | $20,642,000 | +11.0% | 110,000 | +4.8% | 2.23% | -14.4% |
| MGNX | Sell | MACROGENICS INC | $18,846,000 | +223.8% | 675,000 | -32.5% | 2.04% | +149.8% |
| NKTR | Sell | NEKTAR THERAPEUTICS | $18,296,000 | -4.7% | 790,000 | -26.5% | 1.98% | -26.5% |
| GILD | New | GILEAD SCIENCES INC | $17,696,000 | – | 230,000 | +100.0% | 1.91% | – |
| LLY | Buy | LILLY ELI & CO | $17,239,000 | +24.3% | 105,000 | +5.0% | 1.86% | -4.2% |
| ANTM | ANTHEM INC | $17,094,000 | +15.8% | 65,000 | 0.0% | 1.85% | -10.6% | |
| ABT | Buy | ABBOTT LABS | $16,915,000 | +26.1% | 185,000 | +8.8% | 1.83% | -2.8% |
| AXNX | Buy | AXONICS MODULATION TECH INC | $16,502,000 | +39.7% | 470,000 | +1.1% | 1.78% | +7.7% |
| ABMD | Sell | ABIOMED INC | $16,426,000 | +28.6% | 68,000 | -22.7% | 1.78% | -0.8% |
| IMMU | Sell | IMMUNOMEDICS INC | $16,302,000 | +105.0% | 460,000 | -22.0% | 1.76% | +58.1% |
| MYOK | Sell | MYOKARDIA INC | $15,459,000 | +83.2% | 160,000 | -11.1% | 1.67% | +41.3% |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $15,353,000 | +222.3% | 210,000 | +50.0% | 1.66% | +148.7% |
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $15,120,000 | +26.3% | 137,032 | +14.2% | 1.63% | -2.6% |
| GH | Buy | GUARDANT HEALTH INC | $15,009,000 | +23.2% | 185,000 | +5.7% | 1.62% | -5.0% |
| CNC | Buy | CENTENE CORP DEL | $14,895,000 | +43.3% | 234,378 | +33.9% | 1.61% | +10.4% |
| XLRN | Buy | ACCELERON PHARMA INC | $14,767,000 | +134.7% | 155,000 | +121.4% | 1.60% | +81.0% |
| CVS | Sell | CVS HEALTH CORP | $14,748,000 | -4.4% | 227,000 | -12.7% | 1.59% | -26.3% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $14,395,000 | -21.9% | 410,000 | -27.4% | 1.56% | -39.8% |
| ARNA | Sell | ARENA PHARMACEUTICALS INC | $13,268,000 | +31.6% | 210,778 | -12.2% | 1.43% | +1.5% |
| SGEN | Sell | SEATTLE GENETICS INC | $12,744,000 | +29.9% | 75,000 | -11.8% | 1.38% | +0.2% |
| MRK | Sell | MERCK & CO INC | $12,373,000 | -2.5% | 160,000 | -3.0% | 1.34% | -24.8% |
| ITCI | Sell | INTRA CELLULAR THERAPIES INC | $12,193,000 | +39.8% | 475,000 | -16.3% | 1.32% | +7.8% |
| MDT | MEDTRONIC PLC | $11,993,000 | +1.7% | 130,780 | 0.0% | 1.30% | -21.5% | |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $11,417,000 | +14.2% | 100,000 | -23.1% | 1.23% | -11.9% |
| COO | Buy | COOPER COS INC | $11,346,000 | +71.5% | 40,000 | +66.7% | 1.23% | +32.3% |
| LIVN | Buy | LIVANOVA PLC | $10,589,000 | +23.2% | 220,000 | +15.8% | 1.14% | -5.1% |
| ADVM | Sell | ADVERUM BIOTECHNOLOGIES INC | $10,440,000 | +94.3% | 500,000 | -9.1% | 1.13% | +49.8% |
| ISRG | Sell | INTUITIVE SURGICAL INC | $9,687,000 | -15.0% | 17,000 | -26.1% | 1.05% | -34.4% |
| LVGO | New | LIVONGO HEALTH INC | $9,399,000 | – | 125,000 | +100.0% | 1.02% | – |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $9,333,000 | -14.6% | 340,000 | -6.8% | 1.01% | -34.2% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $9,197,000 | +5.6% | 62,095 | -22.4% | 0.99% | -18.5% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $9,150,000 | -18.7% | 75,000 | -42.3% | 0.99% | -37.2% |
| AERI | Sell | AERIE PHARMACEUTICALS INC | $8,708,000 | -10.4% | 590,000 | -18.1% | 0.94% | -30.9% |
| XNCR | Sell | XENCOR INC | $8,421,000 | -6.2% | 260,000 | -13.4% | 0.91% | -27.6% |
| EW | Buy | EDWARDS LIFESCIENCES CORP | $8,293,000 | -22.9% | 120,000 | +110.5% | 0.90% | -40.5% |
| DVAX | Sell | DYNAVAX TECHNOLOGIES CORP | $8,209,000 | +132.5% | 925,534 | -7.4% | 0.89% | +79.2% |
| BAX | New | BAXTER INTL INC | $8,180,000 | – | 95,000 | +100.0% | 0.88% | – |
| REGN | New | REGENERON PHARMACEUTICALS | $7,796,000 | – | 12,500 | +100.0% | 0.84% | – |
| HCA | Sell | HCA HEALTHCARE INC | $7,280,000 | -10.0% | 75,000 | -16.7% | 0.79% | -30.6% |
| EXAS | Sell | EXACT SCIENCES CORP | $6,955,000 | +15.0% | 80,000 | -23.3% | 0.75% | -11.3% |
| TMO | THERMO FISHER SCIENTIFIC INC | $6,884,000 | +27.8% | 19,000 | 0.0% | 0.74% | -1.5% | |
| ZBH | Sell | ZIMMER BIOMET HOLDINGS INC | $6,804,000 | -15.9% | 57,000 | -28.8% | 0.74% | -35.1% |
| BLUE | Buy | BLUEBIRD BIO INC | $6,580,000 | +113.7% | 107,797 | +60.9% | 0.71% | +65.0% |
| SGMO | Sell | SANGAMO THERAPEUTICS INC | $6,048,000 | +35.6% | 675,000 | -3.6% | 0.65% | +4.5% |
| ALKS | Sell | ALKERMES PLC | $6,016,000 | +4.6% | 310,000 | -22.3% | 0.65% | -19.4% |
| FGEN | Sell | FIBROGEN INC | $5,877,000 | -32.4% | 145,000 | -42.0% | 0.64% | -47.8% |
| SILK | Sell | SILK ROAD MEDICAL INC | $5,865,000 | +6.5% | 140,000 | -20.0% | 0.63% | -17.9% |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $5,389,000 | +101.2% | 165,000 | +65.0% | 0.58% | +55.2% |
| GKOS | Sell | GLAUKOS CORP | $5,379,000 | +5.6% | 140,000 | -15.2% | 0.58% | -18.5% |
| RVNC | REVANCE THERAPEUTICS INC | $5,372,000 | +65.0% | 220,000 | 0.0% | 0.58% | +27.2% | |
| BDX | Buy | BECTON DICKINSON & CO | $5,025,000 | +56.2% | 21,000 | +50.0% | 0.54% | +20.4% |
| RARE | Sell | ULTRAGENYX PHARMACEUTICAL INC | $4,811,000 | +58.0% | 61,500 | -10.3% | 0.52% | +21.8% |
| AGIO | Sell | AGIOS PHARMACEUTICALS INC | $4,813,000 | +23.3% | 90,000 | -18.2% | 0.52% | -4.9% |
| AIMT | Buy | AIMMUNE THERAPEUTICS INC | $4,762,000 | +100.2% | 285,000 | +72.7% | 0.51% | +54.4% |
| GTHX | Sell | G1 THERAPEUTICS INC | $4,609,000 | +67.2% | 190,000 | -24.1% | 0.50% | +29.0% |
| BIIB | Sell | BIOGEN INC | $4,548,000 | -42.5% | 17,000 | -32.0% | 0.49% | -55.7% |
| RDUS | Buy | RADIUS HEALTH INC | $4,523,000 | +17.9% | 331,826 | +12.5% | 0.49% | -8.9% |
| EPZM | Sell | EPIZYME INC | $4,256,000 | -21.6% | 265,000 | -24.3% | 0.46% | -39.6% |
| OMCL | Sell | OMNICELL INC | $4,237,000 | -25.0% | 60,000 | -30.3% | 0.46% | -42.1% |
| INCY | Sell | INCYTE CORP | $4,159,000 | +13.6% | 40,000 | -20.0% | 0.45% | -12.5% |
| MNTA | Sell | MOMENTA PHARMACEUTICALS INC | $3,992,000 | +20.9% | 120,000 | -1.2% | 0.43% | -6.9% |
| MGTX | Buy | MEIRAGTX HOLDINGS PLC | $3,756,000 | +13.5% | 300,000 | +21.8% | 0.41% | -12.5% |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $3,633,000 | +65.1% | 525,000 | -4.5% | 0.39% | +27.3% |
| RIGL | RIGEL PHARMACEUTICALS INC | $3,177,000 | +17.3% | 1,736,176 | 0.0% | 0.34% | -9.5% | |
| MYOV | New | MYOVANT SCIENCES LTD | $3,093,000 | – | 150,000 | +100.0% | 0.33% | – |
| SWAV | New | SHOCKWAVE MED INC | $2,842,000 | – | 60,000 | +100.0% | 0.31% | – |
| ABEO | Sell | ABEONA THERAPEUTICS INC | $2,696,000 | +35.1% | 925,000 | -2.6% | 0.29% | +4.3% |
| CLLS | CELLECTIS S Aspons ads | $2,574,000 | +93.5% | 144,604 | 0.0% | 0.28% | +49.5% | |
| QURE | Sell | UNIQURE NV | $1,823,000 | -41.6% | 40,466 | -38.5% | 0.20% | -54.9% |
| VRAY | Sell | VIEWRAY INC | $1,736,000 | -18.3% | 775,000 | -8.8% | 0.19% | -36.9% |
| PIRS | PIERIS PHARMACEUTICALS INC | $930,000 | +36.0% | 300,000 | 0.0% | 0.10% | +4.2% | |
| CVX | CHEVRON CORP | $265,000 | +23.3% | 2,974 | 0.0% | 0.03% | -3.3% | |
| XOM | EXXON MOBIL CORP | $241,000 | +17.6% | 5,388 | 0.0% | 0.03% | -10.3% | |
| QCOM | New | QUALCOMM INC | $217,000 | – | 2,381 | +100.0% | 0.02% | – |
| IBM | Sell | INTERNATIONAL BUSINESS MACHS | $192,000 | -22.0% | 1,587 | -28.4% | 0.02% | -38.2% |
| JHG | Sell | JANUS HENDERSON GROUP PLC | $183,000 | +12.3% | 8,645 | -18.8% | 0.02% | -13.0% |
| F | FORD MTR CO DEL | $177,000 | +25.5% | 29,164 | 0.0% | 0.02% | -5.0% | |
| JPM | New | JPMORGAN CHASE & CO | $162,000 | – | 1,723 | +100.0% | 0.02% | – |
| DIS | New | DISNEY WALT CO | $149,000 | – | 1,338 | +100.0% | 0.02% | – |
| PFE | New | PFIZER INC | $147,000 | – | 4,508 | +100.0% | 0.02% | – |
| BUD | New | ANHEUSER BUSCH INBEV SA/NVsponsored adr | $138,000 | – | 2,806 | +100.0% | 0.02% | – |
| NLOK | New | NORTONLIFELOCK INC | $137,000 | – | 6,926 | +100.0% | 0.02% | – |
| WFC | New | WELLS FARGO CO NEW | $135,000 | – | 5,272 | +100.0% | 0.02% | – |
| HAL | New | HALLIBURTON CO | $108,000 | – | 8,299 | +100.0% | 0.01% | – |
| VKTX | Exit | VIKING THERAPEUTICS INC | $0 | – | -200,000 | -100.0% | -0.13% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -50,000 | -100.0% | -0.20% | – |
| BGNE | Exit | BEIGENE LTDsponsored adr | $0 | – | -20,000 | -100.0% | -0.34% | – |
| ICPT | Exit | INTERCEPT PHARMACEUTICALS INC | $0 | – | -40,000 | -100.0% | -0.35% | – |
| STML | Exit | STEMLINE THERAPEUTICS INC | $0 | – | -650,000 | -100.0% | -0.44% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-07-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITEDHEALTH GROUP INC | 40 | Q3 2023 | 4.0% |
| BIOMARIN PHARMACEUTICAL INC | 40 | Q3 2023 | 5.0% |
| ALKERMES PLC | 40 | Q3 2023 | 3.3% |
| LILLY ELI & CO | 39 | Q3 2023 | 5.8% |
| CVS HEALTH CORP | 39 | Q3 2023 | 3.5% |
| INTRA-CELLULAR THERAPIES INC | 39 | Q3 2023 | 2.4% |
| EDWARDS LIFESCIENCES CORP | 39 | Q3 2023 | 1.7% |
| VERTEX PHARMACEUTICALS INC | 38 | Q3 2023 | 4.3% |
| REVANCE THERAPEUTICS INC | 38 | Q3 2023 | 0.9% |
| ABBVIE INC | 37 | Q3 2023 | 4.4% |
View Rhenman & Partners Asset Management AB's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR/A | 2023-11-13 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Rhenman & Partners Asset Management AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.